Retaglutide and tirzepatide are groundbreaking GLP-1 receptor agonists gaining recognition as effective treatment options for type 2 diabetes. These medications stimulate insulin secretion from the pancreas, reduce https://aprildmmi496406.wikipresses.com/6776115/emerging_therapies_for_type_2_diabetes